Eintrag weiter verarbeiten
A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage II...
Gespeichert in:
Zeitschriftentitel: | Journal of Clinical Oncology |
---|---|
Personen und Körperschaften: | , , , , , , , , |
In: | Journal of Clinical Oncology, 23, 2005, 16_suppl, S. 5042-5042 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
American Society of Clinical Oncology (ASCO)
|
Schlagwörter: |
author_facet |
Schroder, W. Witteveen, E. Abadie, S. Campone, M. Viens, P. Jalava, T. Masson, E. Chlistalla, A. Du Bois, A. Schroder, W. Witteveen, E. Abadie, S. Campone, M. Viens, P. Jalava, T. Masson, E. Chlistalla, A. Du Bois, A. |
---|---|
author |
Schroder, W. Witteveen, E. Abadie, S. Campone, M. Viens, P. Jalava, T. Masson, E. Chlistalla, A. Du Bois, A. |
spellingShingle |
Schroder, W. Witteveen, E. Abadie, S. Campone, M. Viens, P. Jalava, T. Masson, E. Chlistalla, A. Du Bois, A. Journal of Clinical Oncology A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage IIC to IV epithelial ovarian cancer Cancer Research Oncology |
author_sort |
schroder, w. |
spelling |
Schroder, W. Witteveen, E. Abadie, S. Campone, M. Viens, P. Jalava, T. Masson, E. Chlistalla, A. Du Bois, A. 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2005.23.16_suppl.5042 A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage IIC to IV epithelial ovarian cancer Journal of Clinical Oncology |
doi_str_mv |
10.1200/jco.2005.23.16_suppl.5042 |
facet_avail |
Online Free |
finc_class_facet |
Medizin |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAwNS4yMy4xNl9zdXBwbC41MDQy |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAwNS4yMy4xNl9zdXBwbC41MDQy |
institution |
DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 |
imprint |
American Society of Clinical Oncology (ASCO), 2005 |
imprint_str_mv |
American Society of Clinical Oncology (ASCO), 2005 |
issn |
0732-183X 1527-7755 |
issn_str_mv |
0732-183X 1527-7755 |
language |
English |
mega_collection |
American Society of Clinical Oncology (ASCO) (CrossRef) |
match_str |
schroder2005aphaseibopenlabelsafetyandpharmacokineticpkstudyofescalatingdosesofptk787zk222584incombinationwithpaclitaxelandcarboplatininpatientsptswithstageiictoivepithelialovariancancer |
publishDateSort |
2005 |
publisher |
American Society of Clinical Oncology (ASCO) |
recordtype |
ai |
record_format |
ai |
series |
Journal of Clinical Oncology |
source_id |
49 |
title |
A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage IIC to IV epithelial ovarian cancer |
title_unstemmed |
A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage IIC to IV epithelial ovarian cancer |
title_full |
A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage IIC to IV epithelial ovarian cancer |
title_fullStr |
A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage IIC to IV epithelial ovarian cancer |
title_full_unstemmed |
A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage IIC to IV epithelial ovarian cancer |
title_short |
A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage IIC to IV epithelial ovarian cancer |
title_sort |
a phase ib, open label, safety and pharmacokinetic (pk) study of escalating doses of ptk787/zk 222584 in combination with paclitaxel and carboplatin in patients (pts) with stage iic to iv epithelial ovarian cancer |
topic |
Cancer Research Oncology |
url |
http://dx.doi.org/10.1200/jco.2005.23.16_suppl.5042 |
publishDate |
2005 |
physical |
5042-5042 |
description |
|
container_issue |
16_suppl |
container_start_page |
5042 |
container_title |
Journal of Clinical Oncology |
container_volume |
23 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792323359906725896 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T11:32:35.025Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=A+phase+IB%2C+open+label%2C+safety+and+pharmacokinetic+%28PK%29+study+of+escalating+doses+of+PTK787%2FZK+222584+in+combination+with+paclitaxel+and+carboplatin+in+patients+%28PTs%29+with+stage+IIC+to+IV+epithelial+ovarian+cancer&rft.date=2005-06-01&genre=article&issn=1527-7755&volume=23&issue=16_suppl&spage=5042&epage=5042&pages=5042-5042&jtitle=Journal+of+Clinical+Oncology&atitle=A+phase+IB%2C+open+label%2C+safety+and+pharmacokinetic+%28PK%29+study+of+escalating+doses+of+PTK787%2FZK+222584+in+combination+with+paclitaxel+and+carboplatin+in+patients+%28PTs%29+with+stage+IIC+to+IV+epithelial+ovarian+cancer&aulast=Du+Bois&aufirst=A.&rft_id=info%3Adoi%2F10.1200%2Fjco.2005.23.16_suppl.5042&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792323359906725896 |
author | Schroder, W., Witteveen, E., Abadie, S., Campone, M., Viens, P., Jalava, T., Masson, E., Chlistalla, A., Du Bois, A. |
author_facet | Schroder, W., Witteveen, E., Abadie, S., Campone, M., Viens, P., Jalava, T., Masson, E., Chlistalla, A., Du Bois, A., Schroder, W., Witteveen, E., Abadie, S., Campone, M., Viens, P., Jalava, T., Masson, E., Chlistalla, A., Du Bois, A. |
author_sort | schroder, w. |
container_issue | 16_suppl |
container_start_page | 5042 |
container_title | Journal of Clinical Oncology |
container_volume | 23 |
description | |
doi_str_mv | 10.1200/jco.2005.23.16_suppl.5042 |
facet_avail | Online, Free |
finc_class_facet | Medizin |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAwNS4yMy4xNl9zdXBwbC41MDQy |
imprint | American Society of Clinical Oncology (ASCO), 2005 |
imprint_str_mv | American Society of Clinical Oncology (ASCO), 2005 |
institution | DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161 |
issn | 0732-183X, 1527-7755 |
issn_str_mv | 0732-183X, 1527-7755 |
language | English |
last_indexed | 2024-03-01T11:32:35.025Z |
match_str | schroder2005aphaseibopenlabelsafetyandpharmacokineticpkstudyofescalatingdosesofptk787zk222584incombinationwithpaclitaxelandcarboplatininpatientsptswithstageiictoivepithelialovariancancer |
mega_collection | American Society of Clinical Oncology (ASCO) (CrossRef) |
physical | 5042-5042 |
publishDate | 2005 |
publishDateSort | 2005 |
publisher | American Society of Clinical Oncology (ASCO) |
record_format | ai |
recordtype | ai |
series | Journal of Clinical Oncology |
source_id | 49 |
spelling | Schroder, W. Witteveen, E. Abadie, S. Campone, M. Viens, P. Jalava, T. Masson, E. Chlistalla, A. Du Bois, A. 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2005.23.16_suppl.5042 A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage IIC to IV epithelial ovarian cancer Journal of Clinical Oncology |
spellingShingle | Schroder, W., Witteveen, E., Abadie, S., Campone, M., Viens, P., Jalava, T., Masson, E., Chlistalla, A., Du Bois, A., Journal of Clinical Oncology, A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage IIC to IV epithelial ovarian cancer, Cancer Research, Oncology |
title | A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage IIC to IV epithelial ovarian cancer |
title_full | A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage IIC to IV epithelial ovarian cancer |
title_fullStr | A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage IIC to IV epithelial ovarian cancer |
title_full_unstemmed | A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage IIC to IV epithelial ovarian cancer |
title_short | A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage IIC to IV epithelial ovarian cancer |
title_sort | a phase ib, open label, safety and pharmacokinetic (pk) study of escalating doses of ptk787/zk 222584 in combination with paclitaxel and carboplatin in patients (pts) with stage iic to iv epithelial ovarian cancer |
title_unstemmed | A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage IIC to IV epithelial ovarian cancer |
topic | Cancer Research, Oncology |
url | http://dx.doi.org/10.1200/jco.2005.23.16_suppl.5042 |